CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 4 Open-market sale Chief Executive Officer sold 125,000 shares at $1.92 ($240,000)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 4 Open-market sale Director sold 7,500 shares at $2.83 ($21,225)
- 8-K Event Material agreement
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
Page 15 of 45 · 895 filings